Sevyam Treatments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 214.91%
- Profit Growth 219.05%
- Ebitda 211.15%
- Total Assets %
About Sevyam Treatments
Sevyam Treatments Private Limited (STPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 January 2018 (Seven years and one month 0 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pushp Mookim, Sapna Mookim, and Davesh Mookim serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85300RJ2018PTC059910
-
Company No.
059910
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jan 2018
-
Date of AGM
23 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Sevyam Treatments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushp Mookim
|
Director | 01-Jan-2018 | Current |
|
Sapna Mookim
|
Director | 01-Jan-2018 | Current |
|
Davesh Mookim
|
Director | 01-Jan-2018 | Current |
Financial Performance of Sevyam Treatments.
Sevyam Treatments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 214.91% increase. The company also saw a substantial improvement in profitability, with a 219.05% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sevyam Treatments?
Unlock access to Sevyam Treatments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Inter Jewels Export LimitedPushp Mookim and Sapna Mookim are mutual person
-
Saaol Heart Centre Private Limited
Pushp Mookim and Davesh Mookim are mutual person
-
Anshdaani Foundation
Sapna Mookim is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sevyam Treatments?
Unlock and access historical data on people associated with Sevyam Treatments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sevyam Treatments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sevyam Treatments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.